Eloxx Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.09 | -100% | -0.1888 | -100% |
| P/S |
|
0 | 33.5 | -100% |
|
|
| P/BV |
|
-0.4146 | 4.61 | -108.98% |
|
|
| P/FCF |
|
-0.7393 | 39.66 | -101.86% |
|
|
| Ev/Ebitda |
|
0.0408 | -19.46 | -100.21% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
0.0778 | 45.47 | -99.83% |
|
|
| E/P |
|
-1.54 | 0.0172 | -9028.9% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -14.42 | -100% | -5135.01 | -100% |
| ROE |
|
-616.05 | 9.01 | -6937.13% |
|
|
| ROA |
|
-109 | 0.0151 | -719826.17% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -26.5 | -100% |
|
|
| ROCE |
|
328.04 | 13.75 | 2285.23% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.3895 | -3.73 | -89.55% | -0.3528 | +10.4% |
| Nеt Debt/Ebitda |
|
0.1686 | -3.19 | -105.28% |
|
|
| Debt/Ratio |
|
0.6351 | 0.1777 | 257.34% |
|
|
| Debt/Equity |
|
0.6667 | 1.57 | -57.58% |
|
|
| Debt/Net Income |
|
-0.6542 | 0.8429 | -177.61% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-62.5 | 73.67 | -184.84% | ||
| Growth impulse Ebitda in 5 years |
|
-43.6 | 15.28 | -385.34% | ||
| Growth impulse Net Income in 5 years |
|
-58.22 | -33.08 | 76% | ||
| Growth impulse FCF in 5 years |
|
-54.37 | -6.99 | 677.83% | ||
| Growth impulse EPS in 5 years |
|
-70.64 | -59.11 | 19.51% |
IP Score
3/10
